Barclays Maintains Underweight on Clorox, Lowers Price Target to $117
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Underweight rating on Clorox (NYSE:CLX) and has lowered the price target from $124 to $117.
July 20, 2023 | 11:04 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barclays has maintained an Underweight rating on Clorox and lowered the price target from $124 to $117, which could negatively impact the stock's performance.
The lowered price target by Barclays indicates a bearish outlook on Clorox. This could lead to a decrease in the stock's price as investors adjust their expectations based on this new target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100